These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28009985)

  • 21. Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis.
    Liu H; Chen J; Huang Y; Zhang Y; Ni Y; Xu N; Zhao F; Tang Y; Liu H; Sun G; Shen P; Liu Z; Huang J; Liao B; Zeng H
    Int J Surg; 2024 Jun; 110(6):3923-3936. PubMed ID: 38573063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
    Zhang CT; He KC; Pan F; Li Y; Wu J
    World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis.
    Zhang H; Jin T; Peng Y; Luan S; Li X; Xiao X; Yuan Y
    Int J Surg; 2024 Jul; 110(7):4370-4381. PubMed ID: 38526514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis.
    Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J
    Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: a meta-analysis.
    Huang X; Gao P; Sun J; Chen X; Song Y; Zhao J; Xu H; Wang Z
    Int J Cancer; 2015 Jan; 136(1):21-33. PubMed ID: 24803400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.
    Gu Y; Wan C; Qiu J; Cui Y; Jiang T; Zhuang Z
    PLoS One; 2020; 15(2):e0224001. PubMed ID: 32027658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.
    Wang HL; Zhou PY; Liu P; Zhang Y
    Mol Biol Rep; 2014 Jul; 41(7):4481-92. PubMed ID: 24610350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is It a Protective Factor of Helicobacter pylori Infection in Overall Survival of All Gastric Cancer? Evidence from Meta-Analysis.
    Zheng F; Sun Z; Kan J; Yin J; Du F; Shen G; Wang Z; Ren D; Bao X; Zhao J
    J Environ Pathol Toxicol Oncol; 2017; 36(4):309-320. PubMed ID: 29431063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
    Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
    World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.
    Shen H; Che K; Cong L; Dong W; Zhang T; Liu Q; Du J
    Oncotarget; 2017 May; 8(22):36812-36823. PubMed ID: 28415658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of magnifying narrow-band imaging for early gastric cancer: A meta-analysis.
    Hu YY; Lian QW; Lin ZH; Zhong J; Xue M; Wang LJ
    World J Gastroenterol; 2015 Jul; 21(25):7884-94. PubMed ID: 26167089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis.
    Jia Z; Zheng M; Jiang J; Cao D; Wu Y; Zhang Y; Fu Y; Cao X
    BMC Cancer; 2022 Feb; 22(1):155. PubMed ID: 35135494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis.
    Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A
    Sci Rep; 2018 Sep; 8(1):13379. PubMed ID: 30190486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
    Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
    PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Performance of Magnifying Endoscopy for Helicobacter pylori Infection: A Meta-Analysis.
    Qi Q; Guo C; Ji R; Li Z; Zuo X; Li Y
    PLoS One; 2016; 11(12):e0168201. PubMed ID: 27992489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma.
    Sarkozy C; Huet S; Carlton VE; Fabiani B; Delmer A; Jardin F; Delfau-Larue MH; Hacini M; Ribrag V; Guidez S; Faham M; Salles G
    Oncotarget; 2017 Jan; 8(5):8765-8774. PubMed ID: 28060738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.